Syros Pharmaceuticals Inc.

Insiders Updates

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Syros Pharmaceuticals

Analysts Viewpoint

Syros Pharmaceuticals Inc’s recent filing unveils that its President & CEO Chee Conley acquired Company’s shares for reported $85420.0 on

Analysts Viewpoint

In a filing, Syros Pharmaceuticals Inc revealed its President & CEO Chee Conley acquired Company’s shares for reported $85420.0 on

Analysts Viewpoint

Syros Pharmaceuticals Inc’s filing revealed that its President & CEO Chee Conley acquired Company’s shares for reported $85420.0 on Sep

Stock Earnings

Syros Pharmaceuticals Inc.’s recently made public that its President & CEO Chee Conley acquired Company’s shares for reported $85420.0 on

Stock Earnings

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Insiders Updates

Syros Pharmaceuticals Inc.’s filing revealed that its President & CEO Chee Conley acquired Company’s shares for reported $85420.0 on Sep

Tag: Syros Pharmaceuticals Inc.